1.646.889.1200|info@lifescipublicrelations.com

Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen

/, video/Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen

Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen

Jim Cramer chats with Arrowhead Pharmaceuticals CEO Christopher Anzalone about projects the company is working on to silence genes that cause rare genetic disorders.

By | 2019-10-21T13:38:22-04:00 October 17th, 2019|News, video|Comments Off on Arrowhead CEO breaks down drug partnerships with Johnson & Johnson and Amgen

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.